UY34719A - Proceso para la producción de inhibidores de crr - Google Patents
Proceso para la producción de inhibidores de crrInfo
- Publication number
- UY34719A UY34719A UY0001034719A UY34719A UY34719A UY 34719 A UY34719 A UY 34719A UY 0001034719 A UY0001034719 A UY 0001034719A UY 34719 A UY34719 A UY 34719A UY 34719 A UY34719 A UY 34719A
- Authority
- UY
- Uruguay
- Prior art keywords
- crr
- inhibitors
- production
- pág
- escanear
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- FWYUJENICVGSJH-UHFFFAOYSA-M sodium;2-[bis[2-[2-(2-methyl-5-nitroimidazol-1-yl)ethoxy]-2-oxoethyl]amino]acetate Chemical compound [Na+].CC1=NC=C([N+]([O-])=O)N1CCOC(=O)CN(CC([O-])=O)CC(=O)OCCN1C([N+]([O-])=O)=CN=C1C FWYUJENICVGSJH-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162852 | 2012-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY34719A true UY34719A (es) | 2013-10-31 |
Family
ID=47998462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001034719A UY34719A (es) | 2012-04-02 | 2013-04-02 | Proceso para la producción de inhibidores de crr |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8680280B2 (enExample) |
| EP (1) | EP2834229B1 (enExample) |
| JP (1) | JP6255550B2 (enExample) |
| AR (1) | AR090566A1 (enExample) |
| DK (1) | DK2834229T3 (enExample) |
| ES (1) | ES2641862T3 (enExample) |
| TW (1) | TW201400474A (enExample) |
| UY (1) | UY34719A (enExample) |
| WO (1) | WO2013149926A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| AR090566A1 (es) | 2012-04-02 | 2014-11-19 | Boehringer Ingelheim Int | Proceso para la produccion de inhibidores de crr |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
| US11382907B2 (en) | 2017-04-05 | 2022-07-12 | Alkahest, Inc. | Methods and compositions for treating aging-associated impairments using CCR3-inhibitors |
| EA201992356A1 (ru) | 2017-04-05 | 2020-03-23 | Алкахест Инк. | Способ и композиция для лечения заболевания, связанного с сетчаткой глаза, с использованием ингибитора ccr3 |
| US11426399B2 (en) | 2018-05-15 | 2022-08-30 | Alkahest, Inc. | Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase |
| US12692301B2 (en) | 2020-06-11 | 2026-07-28 | Alkahest Inc. | Methods of improving retina-associated disease outcome using CCR3-inhibitors |
| CA3221177A1 (en) | 2021-11-01 | 2023-05-04 | Meghan Kerrisk Campbell | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7907121L (sv) | 1979-08-27 | 1981-02-28 | Astra Laekemedel Ab | Ftalimidinderivat |
| JP2807577B2 (ja) | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| JPH08134041A (ja) * | 1994-11-10 | 1996-05-28 | Fuji Photo Film Co Ltd | ピラゾールアミド類の製造方法 |
| WO1999037619A1 (en) | 1998-01-21 | 1999-07-29 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| EP1052992A1 (en) | 1998-02-02 | 2000-11-22 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| US6140349A (en) | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| EP1725235B1 (en) | 2004-02-05 | 2009-04-15 | Schering Corporation | Piperidine derivatives useful as ccr3 antagonists |
| JP2006137718A (ja) | 2004-11-12 | 2006-06-01 | Astellas Pharma Inc | インドール若しくはインダゾール誘導体 |
| WO2006083390A2 (en) | 2004-12-07 | 2006-08-10 | Children's Hospital Medical Center | Eotaxin-3 in eosinophilic esophagitis |
| DOP2006000051A (es) | 2005-02-24 | 2006-08-31 | Lilly Co Eli | Inhibidores de vegf-r2 y métodos |
| CA2647448A1 (en) | 2006-04-12 | 2007-10-18 | Pfizer Limited | Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| GB0701992D0 (en) | 2007-02-02 | 2007-03-14 | 7Tm Pharma As | Grehlin Receptor Modulators |
| US8008092B2 (en) | 2007-10-09 | 2011-08-30 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
| TW201000446A (en) | 2008-05-30 | 2010-01-01 | Astrazeneca Ab | New compounds useful in pain therapy |
| US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| AR090566A1 (es) | 2012-04-02 | 2014-11-19 | Boehringer Ingelheim Int | Proceso para la produccion de inhibidores de crr |
| US20130261153A1 (en) | 2012-04-03 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Use of ccr3-inhibitors |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
-
2013
- 2013-03-27 AR ARP130101059A patent/AR090566A1/es unknown
- 2013-03-27 US US13/851,547 patent/US8680280B2/en active Active
- 2013-03-28 ES ES13712567.0T patent/ES2641862T3/es active Active
- 2013-03-28 DK DK13712567.0T patent/DK2834229T3/da active
- 2013-03-28 JP JP2015503828A patent/JP6255550B2/ja active Active
- 2013-03-28 WO PCT/EP2013/056638 patent/WO2013149926A1/en not_active Ceased
- 2013-03-28 EP EP13712567.0A patent/EP2834229B1/en active Active
- 2013-04-01 TW TW102111742A patent/TW201400474A/zh unknown
- 2013-04-02 UY UY0001034719A patent/UY34719A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6255550B2 (ja) | 2018-01-10 |
| TW201400474A (zh) | 2014-01-01 |
| JP2015516959A (ja) | 2015-06-18 |
| DK2834229T3 (da) | 2017-11-20 |
| EP2834229A1 (en) | 2015-02-11 |
| WO2013149926A1 (en) | 2013-10-10 |
| ES2641862T3 (es) | 2017-11-14 |
| US20130261307A1 (en) | 2013-10-03 |
| EP2834229B1 (en) | 2017-08-09 |
| US8680280B2 (en) | 2014-03-25 |
| AR090566A1 (es) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
| UY34550A (es) | Bencilpirazoles sustituidos | |
| UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| UY34145A (es) | Compuestos inhibidores de metaloenzimas | |
| UY34146A (es) | Compuestos inhibidores de metaloenzimas | |
| UY33925A (es) | Inhibidores tricíclicos de quinasas | |
| UY34591A (es) | Compuestos de imidazopirrolidinona | |
| UY34559A (es) | Inhibidores de bromodominios | |
| MX378288B (es) | Inhibidores de pirimidina del fgfr4. | |
| UY34374A (es) | Benzilindazoles sustituidos | |
| UY34156A (es) | Compuestos inhibidores de metaloenzimas | |
| UY34648A (es) | Amidas como inhibidores de pim | |
| UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
| UY34660A (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
| UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
| UY34393A (es) | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia | |
| UY34541A (es) | ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?. | |
| UY34108A (es) | ?proceso para la fabricación de sustratos revestidos?. | |
| UY34817A (es) | Tienopirimidinas | |
| UY34034A (es) | Triazolopiridinas | |
| UY34767A (es) | Inhibidores cíclicos del enlace éter de dgat1 | |
| UY34523A (es) | Derivados de betulina | |
| UY34661A (es) | Inhibidores de benzodioxano de la producción de leucotrieno para terapia de combinación | |
| AR095075A1 (es) | Acoplamiento electroquímico de anilinas |